The Claim
In adults with upper-body obesity and/or type 2 diabetes, niacin suppresses fasting free fatty acid release from adipose tissue by approximately 55% on average, with substantial individual variation (31–73%).
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with upper-body obesity or type 2 diabetes, niacin reduces the release of free fatty acids from fat tissue by about 55% on average, though the effect varies between individuals from 31% to 73%.
See the scientific wording
In adults with upper-body obesity and/or type 2 diabetes, niacin suppresses fasting free fatty acid release from adipose tissue by approximately 55% on average, with substantial individual variation (31–73%), indicating that niacin’s antilipolytic effect is potent but not uniformly effective across this population.
Niacin binds to a receptor on fat cells, which triggers a signal that reduces the activity of proteins that break down fat. In people with obesity or type 2 diabetes, these fat-breaking proteins do not respond properly to signals that normally stop fat breakdown, so niacin can only partially reduce fat release, and how much it works varies between individuals.
What the research says
1 studyStudy: Adipose Tissue Resistance to the Antilipolytic Effect of Insulin and Niacin in Humans With Obesity.
In people with obesity or type 2 diabetes, niacin reduces fat breakdown in fat tissue, but some people respond much more than others — and this study shows that’s true, even though it didn’t measure the exact percentage.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.